Effect of PPAR activators on cytokine-stimulated cyclooxygenase-2 expression in human colorectal carcinoma cells

Exp Cell Res. 2001 Jul 1;267(1):73-80. doi: 10.1006/excr.2001.5233.

Abstract

Cyclooxygenase-2 (COX-2) expression is up-regulated in colorectal cancer tissue. Peroxisome proliferator-activated receptors (PPARs) are expressed in human colorectal tissue and activation of PPARs can alter COX-2 expression. In macrophages, activation of PPARs down-regulates COX-2 expression. We examined the effect of PPARalpha and PPARgamma ligands on untreated and TNF-alpha-induced COX-2 expression in the human colorectal epithelial cell line HT-29. The expression of PPARalpha and PPARgamma was confirmed in these cells. TNF-alpha, an inflammatory cytokine, increased COX-2 expression via the NFkappaB pathway. In the absence of TNF-alpha, WY14643 (PPARalpha activator) caused an increase, while BRL49653 (PPARgamma activator) did not alter COX-2 expression. When HT-29 cells were incubated with TNF-alpha and WY14643, a further increase in COX-2 expression was detected. Incubation with TNF-alpha and BRL49653 caused an additional twofold increase in COX-2 expression. Our results suggest that both PPARalpha signaling and TNF-alpha signaling increase COX-2 expression by independent pathways, while PPARgamma stimulates COX-2 expression by up-regulation of the TNF-alpha pathway.

MeSH terms

  • Adenocarcinoma / enzymology*
  • Colorectal Neoplasms / enzymology*
  • Cyclooxygenase 2
  • Gene Expression Regulation, Enzymologic
  • Gene Expression Regulation, Neoplastic
  • HT29 Cells
  • Humans
  • Isoenzymes / biosynthesis*
  • Isoenzymes / genetics
  • Ligands
  • Membrane Proteins
  • Models, Biological
  • Prostaglandin-Endoperoxide Synthases / biosynthesis*
  • Prostaglandin-Endoperoxide Synthases / genetics
  • Pyrimidines / pharmacology
  • Receptor Cross-Talk
  • Receptors, Cytoplasmic and Nuclear / agonists*
  • Rosiglitazone
  • Signal Transduction
  • Thiazoles / pharmacology
  • Thiazolidinediones*
  • Transcription Factors / agonists*
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Isoenzymes
  • Ligands
  • Membrane Proteins
  • Pyrimidines
  • Receptors, Cytoplasmic and Nuclear
  • Thiazoles
  • Thiazolidinediones
  • Transcription Factors
  • Tumor Necrosis Factor-alpha
  • Rosiglitazone
  • pirinixic acid
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases